RFG Advisory LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

RFG Advisory LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,635 shares of the healthcare conglomerate’s stock after purchasing an additional 150 shares during the quarter. RFG Advisory LLC’s holdings in UnitedHealth Group were worth $2,344,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. Quarry LP raised its position in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on UNH. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $627.74.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $532.26 on Friday. The firm’s fifty day simple moving average is $542.24 and its two-hundred day simple moving average is $563.54. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.